U.S. Physical Therapy, Inc. (USPH) Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. cut its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 39.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,957 shares of the company’s stock after selling 23,847 shares during the quarter. Russell Investments Group Ltd. owned about 0.29% of U.S. Physical Therapy worth $2,210,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of USPH. Rhumbline Advisers grew its position in U.S. Physical Therapy by 15.8% during the 3rd quarter. Rhumbline Advisers now owns 40,729 shares of the company’s stock valued at $2,503,000 after purchasing an additional 5,570 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. boosted its holdings in shares of U.S. Physical Therapy by 98.7% during the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 13,648 shares of the company’s stock valued at $839,000 after acquiring an additional 6,780 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its holdings in shares of U.S. Physical Therapy by 59.3% during the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 4,700 shares of the company’s stock valued at $289,000 after acquiring an additional 1,750 shares during the last quarter. BNP Paribas Arbitrage SA boosted its holdings in shares of U.S. Physical Therapy by 57.1% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 6,452 shares of the company’s stock valued at $396,000 after acquiring an additional 2,346 shares during the last quarter. Finally, Wedge Capital Management L L P NC boosted its holdings in shares of U.S. Physical Therapy by 13.7% during the 3rd quarter. Wedge Capital Management L L P NC now owns 26,526 shares of the company’s stock valued at $1,630,000 after acquiring an additional 3,200 shares during the last quarter. Institutional investors and hedge funds own 94.12% of the company’s stock.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $72.56, for a total transaction of $145,120.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Christopher J. Reading sold 15,000 shares of U.S. Physical Therapy stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $66.52, for a total transaction of $997,800.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 31,875 shares of company stock valued at $2,173,623. 3.10% of the stock is currently owned by insiders.

A number of brokerages have recently issued reports on USPH. Cantor Fitzgerald reaffirmed a “buy” rating and set a $80.00 price target on shares of U.S. Physical Therapy in a report on Tuesday. BidaskClub raised shares of U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a report on Thursday, September 28th. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a research note on Saturday, January 6th. Finally, Barrington Research cut shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $73.80.

U.S. Physical Therapy, Inc. (NYSE USPH) traded up $0.15 during midday trading on Friday, reaching $74.95. 40,816 shares of the company’s stock were exchanged, compared to its average volume of 54,461. U.S. Physical Therapy, Inc. has a 12 month low of $56.50 and a 12 month high of $78.00. The company has a market cap of $941.07, a PE ratio of 45.15, a price-to-earnings-growth ratio of 2.76 and a beta of 1.09. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.04 and a current ratio of 2.04.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). U.S. Physical Therapy had a net margin of 5.29% and a return on equity of 13.37%. The company had revenue of $103.03 million for the quarter, compared to analysts’ expectations of $102.69 million. sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.07 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “U.S. Physical Therapy, Inc. (USPH) Shares Sold by Russell Investments Group Ltd.” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/01/13/u-s-physical-therapy-inc-usph-shares-sold-by-russell-investments-group-ltd.html.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply